Ainos Operating Margin from 2010 to 2025

AIMDW Stock  USD 0.22  0.07  46.67%   
Ainos Operating Profit Margin yearly trend continues to be fairly stable with very little volatility. Operating Profit Margin will likely drop to -102.2 in 2025.
Check Ainos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ainos' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Interest Expense of 234.1 K or Total Revenue of 133.4 K, as well as many indicators such as Price To Sales Ratio of 58.82, Dividend Yield of 0.0014 or PTB Ratio of 0.41. Ainos financial statements analysis is a perfect complement when working with Ainos Valuation or Volatility modules.
  
Check out the analysis of Ainos Correlation against competitors.

Latest Ainos' Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Ainos Inc over the last few years. It is Ainos' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ainos' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (359.85) %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Ainos Operating Margin Regression Statistics

Arithmetic Mean(151.12)
Geometric Mean35.51
Coefficient Of Variation(170.48)
Mean Deviation153.95
Median(86.97)
Standard Deviation257.62
Sample Variance66,369
Range1K
R-Value0.34
Mean Square Error63,053
R-Squared0.11
Significance0.20
Slope18.21
Total Sum of Squares995,537

Ainos Operating Margin History

2025 -102.2
2024 -97.33
2023 -108.15
2022 -3.97
2021 -6.5
2020 -86.97
2019 -134.72

About Ainos Financial Statements

Ainos investors use historical fundamental indicators, such as Ainos' Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ainos. Please read more on our technical analysis and fundamental analysis pages.
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ainos Stock Analysis

When running Ainos' price analysis, check to measure Ainos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ainos is operating at the current time. Most of Ainos' value examination focuses on studying past and present price action to predict the probability of Ainos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ainos' price. Additionally, you may evaluate how the addition of Ainos to your portfolios can decrease your overall portfolio volatility.